The bacterial ribosome, a promising focus for structure-based drug design.

Abstract:

:Recent crystal structures of the bacterial ribosome have identified the complex molecular interactions involved in antibiotic-ribosome recognition. Insights into the binding of aminoglycosides, macrolides, tetracyclines and other antibiotics provide opportunities for computational, structure-based approaches to be used in the design of appropriate modifications to existing antibiotics as well as in the discovery of completely new drug classes.

journal_name

Curr Opin Pharmacol

authors

Knowles DJ,Foloppe N,Matassova NB,Murchie AI

doi

10.1016/s1471-4892(02)00205-9

keywords:

subject

Has Abstract

pub_date

2002-10-01 00:00:00

pages

501-6

issue

5

eissn

1471-4892

issn

1471-4973

pii

S1471489202002059

journal_volume

2

pub_type

杂志文章,评审
  • New and emerging anti-fibrotic therapeutics entering or already in clinical trials in chronic liver diseases.

    abstract::Chronic liver diseases with different etiologies represent a major public health issue worldwide. Liver fibrosis is the common feature of almost all chronic liver diseases and remains a key determinant of clinical prognosis. Over the last two decades, basic science studies have uncovered molecular mechanisms underlyin...

    journal_title:Current opinion in pharmacology

    pub_type: 杂志文章,评审

    doi:10.1016/j.coph.2019.09.006

    authors: Lemoinne S,Friedman SL

    更新日期:2019-12-01 00:00:00

  • Promising pharmacologic innovations in treating pulmonary fibrosis.

    abstract::Idiopathic pulmonary fibrosis is the most common form of the interstitial lung diseases and is characterized by chronic progressive pulmonary parenchymal fibrosis. Although the diagnosis and pathophysiology of this disease have been better characterized over the past few years, there remains no effective therapy for t...

    journal_title:Current opinion in pharmacology

    pub_type: 杂志文章,评审

    doi:10.1016/j.coph.2006.03.003

    authors: Bhatt N,Baran CP,Allen J,Magro C,Marsh CB

    更新日期:2006-06-01 00:00:00

  • siRNA and the lung: research tool or therapeutic drug?

    abstract::Oligonucleotide-based therapeutics have been hailed as 'the next great wave of the biotechnology revolution' starting with antisense oligonucleotides (ASOs) nearly 20 years ago to RNA interference (RNAi) currently. Is RNAi just the latest research tool or does it have real potential as a therapeutic drug modality? As ...

    journal_title:Current opinion in pharmacology

    pub_type: 杂志文章,评审

    doi:10.1016/j.coph.2008.04.005

    authors: de Fougerolles A,Novobrantseva T

    更新日期:2008-06-01 00:00:00

  • Invasive treatment in peripheral artery disease.

    abstract::Invasive treatment in peripheral artery disease (PAD) has evolved as a viable alternative to surgical treatment. However, beyond the common pathophysiological substrate, as far as treatment is concerned, each site of atherosclerotic disease (subclavian and vertebral arteries; carotid arteries; intracranial arterial tr...

    journal_title:Current opinion in pharmacology

    pub_type: 杂志文章,评审

    doi:10.1016/j.coph.2018.01.013

    authors: Deftereos SG,Vrachatis DA,Tolis C,Giannopoulos G

    更新日期:2018-04-01 00:00:00

  • 3D intestinal organoids in metabolic research: virtual reality in a dish.

    abstract::The advent of near physiological organoid technology has produced a step change in our understanding of stem cells and has provided the research community with a powerful new cell based tool to model human physiology and disease. We review the pros and cons of intestinal organoid culture systems. The molecular and gen...

    journal_title:Current opinion in pharmacology

    pub_type: 杂志文章,评审

    doi:10.1016/j.coph.2017.09.003

    authors: Tsakmaki A,Fonseca Pedro P,Bewick GA

    更新日期:2017-12-01 00:00:00

  • Immunomodulation in stem-cell transplantation.

    abstract::Acute graft-versus-host disease is a complication that affects 30-60% of patients undergoing allogeneic stem-cell transplantation. The standard for prophylaxis for graft-versus-host disease has historically been the combination of cyclosporine and methotrexate. Recently, tacrolimus has been used more frequently and cu...

    journal_title:Current opinion in pharmacology

    pub_type: 杂志文章,评审

    doi:10.1016/s1471-4892(02)00174-1

    authors: Abo-Zena RA,Horwitz ME

    更新日期:2002-08-01 00:00:00

  • Chronotherapy of cardiac and vascular disease: timing medications to circadian rhythms to optimize treatment effects and outcomes.

    abstract::Circadian rhythms impact cardiac and vascular pathophysiology, resulting in 24-hour patterning of symptoms and life-threatening/ending events (chronopathology), plus kinetics and dynamics of medications (chronopharmacology), resulting in administration-time differences in efficacy and safety. Scheduling medications ac...

    journal_title:Current opinion in pharmacology

    pub_type: 杂志文章,评审

    doi:10.1016/j.coph.2020.10.014

    authors: Smolensky MH,Hermida RC,Geng YJ

    更新日期:2020-12-03 00:00:00

  • 2-5A antisense treatment of respiratory syncytial virus.

    abstract::Although a prominent cause of upper and lower respiratory tract disease in infants and the elderly, clinical options for treatment of respiratory syncytial virus (RSV) infections remain limited. Historically, attempts to develop vaccines have been unsuccessful, and rapid viral mutation rates have stifled development o...

    journal_title:Current opinion in pharmacology

    pub_type: 杂志文章,评审

    doi:10.1016/j.coph.2005.05.003

    authors: Leaman DW

    更新日期:2005-10-01 00:00:00

  • Excitotoxicity, apoptosis and neuropsychiatric disorders.

    abstract::In recent decades there has been an upsurge of interest in mechanisms of cell death in the central nervous system. Much attention has been focused on two cell death processes - excitotoxicity and apoptosis - and much confusion has arisen regarding how one relates to the other, and how either relates to neurological di...

    journal_title:Current opinion in pharmacology

    pub_type: 杂志文章,评审

    doi:

    authors: Olney JW

    更新日期:2003-02-01 00:00:00

  • Assaying dissociable elements of behavioural inhibition and impulsivity: translational utility of animal models.

    abstract::Inhibition is a fundamental property of behaviour required for flexible responding and humans have evolved executive brain systems that can engage inhibitory processes in order to reduce interference from irrelevant distracting stimuli, block unwanted memories and emotions and suppress inappropriate choices and action...

    journal_title:Current opinion in pharmacology

    pub_type: 杂志文章,评审

    doi:10.1016/j.coph.2011.06.006

    authors: Humby T,Wilkinson LS

    更新日期:2011-10-01 00:00:00

  • Opioid receptor signaling: relevance for gastrointestinal therapy.

    abstract::Opiate drugs, such as morphine, are renowned for their analgesic properties. To date, opioid narcotics represent the largest and most potent class of pain relievers available to treat both acute and chronic pain conditions. The use of opiates, however, is severely limited by several adverse side effects. Upon chronic ...

    journal_title:Current opinion in pharmacology

    pub_type: 杂志文章,评审

    doi:10.1016/j.coph.2006.06.007

    authors: Bohn LM,Raehal KM

    更新日期:2006-12-01 00:00:00

  • Pulmonary neuroepithelial bodies as airway sensors: putative role in the generation of dyspnea.

    abstract::The neuroepithelial bodies (NEB) of the intrapulmonary airways (AW) are multimodal AW sensors responding to a variety of stimuli including hypoxia, hypercarbia, and mechanical stretch. NEBs are richly innervated by a diverse population of mostly vagal afferent nerve fibers and owing to their early developmental matura...

    journal_title:Current opinion in pharmacology

    pub_type: 杂志文章,评审

    doi:10.1016/j.coph.2011.04.003

    authors: Domnik NJ,Cutz E

    更新日期:2011-06-01 00:00:00

  • Biased ligands: pathway validation for novel GPCR therapeutics.

    abstract::G protein-coupled receptors (GPCRs), in recent years, have been shown to signal via multiple distinct pathways. Furthermore, biased ligands for some receptors can differentially stimulate or inhibit these pathways versus unbiased endogenous ligands or drugs. Biased ligands can be used to gain a deeper understanding of...

    journal_title:Current opinion in pharmacology

    pub_type: 杂志文章,评审

    doi:10.1016/j.coph.2014.04.002

    authors: Rominger DH,Cowan CL,Gowen-MacDonald W,Violin JD

    更新日期:2014-06-01 00:00:00

  • Antiviral therapeutics for the treatment of Ebola virus infection.

    abstract::There have been significant developments in Ebola virus therapeutics. While the efficacy of several products was evaluated in the recent West Africa outbreak, a licensed treatment for EBOV disease remains elusive. Factors that negatively impacted the execution of clinical trials included an overall lack of world readi...

    journal_title:Current opinion in pharmacology

    pub_type: 杂志文章,评审

    doi:10.1016/j.coph.2016.08.016

    authors: Cardile AP,Downey LG,Wiseman PD,Warren TK,Bavari S

    更新日期:2016-10-01 00:00:00

  • Strategies for hepatitis C therapeutic intervention: now and next.

    abstract::Interferon-alpha-based therapies are the mainstay of hepatitis C treatment. However, these broad immunomodulatory agents, already limited by their side effects, expense and route of administration, are not efficacious in all cases. Therefore, research efforts have focused on identifying additional drugs and therapeuti...

    journal_title:Current opinion in pharmacology

    pub_type: 杂志文章,评审

    doi:10.1016/j.coph.2004.07.003

    authors: Tan SL,He Y,Huang Y,Gale M Jr

    更新日期:2004-10-01 00:00:00

  • Functional implications of neurotransmitter co-release: glutamate and GABA share the load.

    abstract::For decades it has been thought that a neuron releases only one classical neurotransmitter from all of its processes. However, recent work has shown that most neuronal populations release more than one classical transmitter, and indeed that the transmitters can be segregated into different processes of the same neuron...

    journal_title:Current opinion in pharmacology

    pub_type: 杂志文章,评审

    doi:10.1016/j.coph.2005.12.001

    authors: Seal RP,Edwards RH

    更新日期:2006-02-01 00:00:00

  • A role for the gut-to-brain GLP-1-dependent axis in the control of metabolism.

    abstract::Over the past years tremendous amounts of clinical and fundamental data have been generated about GLP-1 and related therapeutic strategies for the treatment of type 2 diabetes. However, the cellular and physiological mechanisms through which GLP-1 is secreted, controls glycemia, and behaves as a therapeutic agent are ...

    journal_title:Current opinion in pharmacology

    pub_type: 杂志文章,评审

    doi:10.1016/j.coph.2009.09.003

    authors: Burcelin R,Serino M,Cabou C

    更新日期:2009-12-01 00:00:00

  • Two way communication between neutrophils and dendritic cells.

    abstract::Neutrophils are instrumental in innate immunity by mediating immediate removal of pathogens. Recent findings demonstrate that they are able to communicate with dendritic cells, which form a link between innate and adaptive immunity by stimulating long-term memory T cell responses. This communication occurs through the...

    journal_title:Current opinion in pharmacology

    pub_type: 杂志文章,评审

    doi:10.1016/j.coph.2006.03.009

    authors: Ludwig IS,Geijtenbeek TB,van Kooyk Y

    更新日期:2006-08-01 00:00:00

  • Vitamin D modulates airway smooth muscle function in COPD.

    abstract::COPD is a disease manifested as persistent airflow obstruction with an enhanced inflammatory response in the airways and lungs to noxious particles and gases which evokes symptoms of dyspnea on exertion, cough and mucus production. Airway smooth muscle plays a central role in the COPD diathesis and is implicated in ma...

    journal_title:Current opinion in pharmacology

    pub_type: 杂志文章,评审

    doi:10.1016/j.coph.2012.01.014

    authors: Banerjee A,Panettieri R Jr

    更新日期:2012-06-01 00:00:00

  • Thymic stromal lymphopoietin: a new cytokine in asthma.

    abstract::Airway epithelial cells provide mechanical and immune protection against pathogens and allergens. Following activation, these cells produce a wide range of cytokines including thymic stromal lymphopoietin (TSLP). Recently it was established that a high level of TSLP is associated with asthma in mice and in humans. The...

    journal_title:Current opinion in pharmacology

    pub_type: 杂志文章,评审

    doi:10.1016/j.coph.2008.03.002

    authors: Rochman Y,Leonard WJ

    更新日期:2008-06-01 00:00:00

  • Targeting the mitochondria to augment myocardial protection.

    abstract::The dynamic regulation of the structure, function and turnover of mitochondria is recognized as an immutable control node maintaining cellular integrity and homeostasis. The term 'mitohormesis' has recently been coined to describe the adaptive reprogramming of mitochondrial biology in response to low levels of metabol...

    journal_title:Current opinion in pharmacology

    pub_type: 杂志文章,评审

    doi:10.1016/j.coph.2007.12.008

    authors: Schwartz DR,Sack MN

    更新日期:2008-04-01 00:00:00

  • Crosstalk between glucocorticoids and mitogen-activated protein kinase signalling pathways.

    abstract::Synthetic glucocorticoids are potent modulators of the immune system, and are clinically invaluable in the treatment of a wide variety of conditions. However, their use can be limited by harmful side effects, and their mechanisms of action remain poorly understood and controversial. It has recently been reported that ...

    journal_title:Current opinion in pharmacology

    pub_type: 杂志文章,评审

    doi:10.1016/s1471-4892(03)00073-0

    authors: Clark AR,Lasa M

    更新日期:2003-08-01 00:00:00

  • Developments in parathyroid hormone and related peptides as bone-formation agents.

    abstract::Osteoporosis is a major and growing healthcare concern. When administered by daily injection, parathyroid hormone (PTH) and its N-terminal fragments and analogs are potent bone-formation agents. Teriparatide, recombinant human PTH(1-34), is likely to be the first anabolic agent approved for treating osteoporosis, desp...

    journal_title:Current opinion in pharmacology

    pub_type: 杂志文章,评审

    doi:10.1016/s1471-4892(02)00154-6

    authors: Fox J

    更新日期:2002-06-01 00:00:00

  • Recent advances of anti-cancer therapies including the use of cell-penetrating peptides.

    abstract::Cancer is one of the major growing public health problems making the development of new anti-cancer treatment strategies still compulsory. Conventionally used chemotherapies are quite often associated with severe side effects. One reason is limited cell-permeability of the used drugs resulting in only poor overall bio...

    journal_title:Current opinion in pharmacology

    pub_type: 杂志文章,评审

    doi:10.1016/j.coph.2019.01.003

    authors: Klimpel A,Lützenburg T,Neundorf I

    更新日期:2019-08-01 00:00:00

  • The role of the adipocyte hormone adiponectin in cardiovascular disease.

    abstract::Adiponectin, a novel hormone made by fat tissue, regulates energy metabolism and endothelial activation. Serum levels of adiponectin are reduced in conditions that are associated with an increased risk of cardiovascular disease, such as diabetes and the metabolic syndrome. Adiponectin trimers assemble into higher-orde...

    journal_title:Current opinion in pharmacology

    pub_type: 杂志文章,评审

    doi:10.1016/j.coph.2005.01.001

    authors: Hug C,Lodish HF

    更新日期:2005-04-01 00:00:00

  • Synaptic localization of neurotransmitter receptors: comparing mechanisms for AMPA and GABAA receptors.

    abstract::Ionotropic neurotransmitter receptors mediate fast synaptic transmission by localizing at postsynapses. Changes in receptor number at synapses induce synaptic plasticity. Thus, mechanisms for the synaptic localization of receptors in basal transmission and synaptic plasticity have been investigated extensively. Recent...

    journal_title:Current opinion in pharmacology

    pub_type: 杂志文章,评审

    doi:10.1016/j.coph.2014.11.011

    authors: Martenson JS,Tomita S

    更新日期:2015-02-01 00:00:00

  • Porous silicon advances in drug delivery and immunotherapy.

    abstract::Biomedical applications of porous silicon include drug delivery, imaging, diagnostics and immunotherapy. This review summarizes new silicon particle fabrication techniques, dynamics of cellular transport, advances in the multistage vector approach to drug delivery, and the use of porous silicon as immune adjuvants. Re...

    journal_title:Current opinion in pharmacology

    pub_type: 杂志文章,评审

    doi:10.1016/j.coph.2013.06.006

    authors: Savage DJ,Liu X,Curley SA,Ferrari M,Serda RE

    更新日期:2013-10-01 00:00:00

  • P2X4 receptors, immunity, and sepsis.

    abstract::Sepsis is life-threatening systemic organ dysfunction caused by a deregulated host response to an infectious insult. Currently, the treatment of sepsis is limited to the use of antibiotics, fluids, and cardiovascular/respiratory support. Despite these interventions, septic mortality remains high, with reduced life qua...

    journal_title:Current opinion in pharmacology

    pub_type: 杂志文章,评审

    doi:10.1016/j.coph.2019.02.011

    authors: Antonioli L,Blandizzi C,Fornai M,Pacher P,Lee HT,Haskó G

    更新日期:2019-08-01 00:00:00

  • Importance of NO and its related compounds in enteric nervous system regulation of gut homeostasis and disease susceptibility.

    abstract::Nitric oxide (NO) produced by the enteric nervous system represents an important regulatory mechanism in gut homeostasis. Aberrant NO signaling contributes significantly toward enteric disease by altering gut motility, vascular tone, blood supply, mucosal barrier function, secretions and immunity. Consequently, there ...

    journal_title:Current opinion in pharmacology

    pub_type: 杂志文章,评审

    doi:10.1016/j.coph.2014.07.009

    authors: Savidge TC

    更新日期:2014-12-01 00:00:00

  • Monitoring vedolizumab and ustekinumab drug levels in patients with inflammatory bowel disease: hype or hope?

    abstract::Therapeutic drug monitoring (TDM) plays a vital role in implementing precision medicine in inflammatory bowel disease (IBD), and may contribute to increased effectiveness, lower rates of drug toxicity and cost savings. While expert panels advocate the use of reactive TDM for anti-tumor necrosis factor (anti-TNF) agent...

    journal_title:Current opinion in pharmacology

    pub_type: 杂志文章,评审

    doi:10.1016/j.coph.2020.09.002

    authors: Alsoud D,Vermeire S,Verstockt B

    更新日期:2020-12-01 00:00:00